Financhill
Back

Sarepta Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sarepta Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

Sarepta Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sarepta Therapeutics Stock

Is Sarepta Therapeutics Stock a Buy?

SRPT Technical Analysis vs Fundamental Analysis

Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy or a Sell?

Sarepta Therapeutics Stock Info

Market Cap:
9.8B
Price in USD:
100.71
Share Volume:
1M

Sarepta Therapeutics 52-Week Range

52-Week High:
173.25
52-Week Low:
97.91
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Sarepta Therapeutics Share Price Forecast

Is Sarepta Therapeutics Stock a Buy?

Fundamental Analysis of Sarepta Therapeutics

Is Sarepta Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Technical Analysis of Sarepta Therapeutics

Should I short Sarepta Therapeutics stock?

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.